Form 4: Salarius Pharmaceuticals Executive Receives Stock Grant
Insider Transaction (Form 4)
Barbara Louise Hibner, Chief Scientific Officer of Salarius Pharmaceuticals, Inc., received 4,216 shares of common stock on August 31, 2026.
Summary
- Grant/award: acquired 4,216 Common Stock on August 31, 2026; holds 4,216 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Barbara Louise Hibner — Officer (Chief Scientific Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Grant/award | Common Stock | 4,216 | — | — | 4,216 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Grant/award (4,216 shares) |
Keywords
insider transaction, Form 4, DCOY, Decoy Therapeutics Inc., neutral, Barbara Louise Hibner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.